Tingting Li

878 total citations
56 papers, 441 citations indexed

About

Tingting Li is a scholar working on Infectious Diseases, Molecular Biology and Dermatology. According to data from OpenAlex, Tingting Li has authored 56 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 13 papers in Molecular Biology and 7 papers in Dermatology. Recurrent topics in Tingting Li's work include SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (6 papers) and Viral Infections and Vectors (5 papers). Tingting Li is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (6 papers) and Viral Infections and Vectors (5 papers). Tingting Li collaborates with scholars based in China, United States and France. Tingting Li's co-authors include Aishun Jin, Xiaojian Han, Meiying Shen, Feiyang Luo, Changjiang Weng, Wang Wang, Jiangnan Li, Xiao Wang, Jingjing Huang and Da Pang and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Tingting Li

47 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tingting Li China 12 171 128 76 57 54 56 441
Yong Wei China 11 155 0.9× 119 0.9× 45 0.6× 56 1.0× 18 0.3× 47 383
Jongwoo Kim South Korea 14 148 0.9× 137 1.1× 19 0.3× 13 0.2× 22 0.4× 43 449
Yunzhang Hu China 16 185 1.1× 310 2.4× 145 1.9× 20 0.4× 16 0.3× 45 592
Adeline Kerviel United Kingdom 10 338 2.0× 236 1.8× 84 1.1× 49 0.9× 11 0.2× 13 641
Xu-Hui Gao China 11 184 1.1× 107 0.8× 28 0.4× 37 0.6× 16 0.3× 21 438
Christina L. Rootes Australia 13 244 1.4× 180 1.4× 96 1.3× 23 0.4× 13 0.2× 18 493
Jessica Katy Skelton United Kingdom 10 121 0.7× 83 0.6× 45 0.6× 9 0.2× 127 2.4× 14 436
Wenbo Sun China 15 234 1.4× 254 2.0× 65 0.9× 92 1.6× 23 0.4× 47 779
Mariluz Araínga United States 16 294 1.7× 219 1.7× 408 5.4× 125 2.2× 33 0.6× 25 885

Countries citing papers authored by Tingting Li

Since Specialization
Citations

This map shows the geographic impact of Tingting Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingting Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingting Li more than expected).

Fields of papers citing papers by Tingting Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tingting Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingting Li. The network helps show where Tingting Li may publish in the future.

Co-authorship network of co-authors of Tingting Li

This figure shows the co-authorship network connecting the top 25 collaborators of Tingting Li. A scholar is included among the top collaborators of Tingting Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tingting Li. Tingting Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Xin, Hongyan Zhang, Xu Wang, et al.. (2025). PAK5 promotes the trastuzumab resistance by increasing HER2 nuclear accumulation in HER2-positive breast cancer. Cell Death and Disease. 16(1). 323–323. 3 indexed citations
2.
Liu, Yu, Tingting Li, & Wei Shi. (2025). Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review. Journal of Dermatological Treatment. 36(1). 2451804–2451804. 1 indexed citations
3.
Wang, Zhaoyang, Yan Liang, Yufei Wang, Tingting Li, & Gong Cheng. (2025). Progress in research on mosquito-borne viruses: Understanding infection, transmission, and control. 6(1). 48–61.
4.
Li, Kong M., et al.. (2024). MDA5-positive dermatomyositis without muscle weakness and rash: a case report and literature review. Frontiers in Medicine. 11. 1482350–1482350.
5.
Huang, Jinhua, et al.. (2024). Mechanisms of Atherosclerotic Plaque Instability. 5(1). 9–12.
6.
Wu, Yan, Hongqing Zhang, Hongqing Zhang, et al.. (2024). A Novel Circular Delta‐XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS‐CoV‐2 Variants in Mice. Journal of Medical Virology. 96(12). e70134–e70134. 1 indexed citations
7.
Shi, Yu, Yanqiu Zhou, Yuhui Gao, et al.. (2023). Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2. PLoS Pathogens. 19(11). e1011789–e1011789. 4 indexed citations
8.
Mu, Song, Shuyi Song, Yanan Hao, et al.. (2022). Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection. Frontiers in Medicine. 9. 952697–952697. 8 indexed citations
9.
Zhang, Xinghai, Huajun Zhang, Tingting Li, et al.. (2022). A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery. Signal Transduction and Targeted Therapy. 7(1). 301–301. 10 indexed citations
10.
Zhang, Panli, Peng Zou, Jinfeng Li, et al.. (2022). Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2. Molecular Therapy — Methods & Clinical Development. 26. 181–190. 1 indexed citations
11.
12.
Liu, Bochao, Xi Tang, Ze Wu, et al.. (2022). Development of a smartphone-based quantum dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies. International Journal of Infectious Diseases. 121. 58–65. 29 indexed citations
13.
Liu, Liqin, Lizhi Zhou, Jie Sun, et al.. (2022). A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice. Frontiers in Microbiology. 13. 854630–854630. 5 indexed citations
14.
Gao, Fengxia, Rui‐Xin Wu, Meiying Shen, et al.. (2022). Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice. iScience. 25(12). 105479–105479. 29 indexed citations
15.
Wang, Tao, Yuanyuan Zhang, Tian-Le Che, et al.. (2022). Human infections with neglected vector-borne pathogens in China: A systematic review. The Lancet Regional Health - Western Pacific. 22. 100427–100427. 6 indexed citations
16.
Du, Li, Meiying Shen, Tingting Li, et al.. (2021). IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities. Frontiers in Molecular Biosciences. 8. 675179–675179. 36 indexed citations
17.
18.
Jia, Lijing, Heng Zhang, Jiaming Wang, et al.. (2021). An interpretable machine learning model based on a quick pre-screening system enables accurate deterioration risk prediction for COVID-19. Scientific Reports. 11(1). 23127–23127. 5 indexed citations
19.
Gao, Fengxia, Jingjing Huang, Tingting Li, et al.. (2021). A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains. Frontiers in Immunology. 12. 789905–789905. 7 indexed citations
20.
Li, Tingting, Jie Feng, Shuzhen Xiao, et al.. (2019). Identification of FDA-Approved Drugs with Activity against Stationary Phase Bartonella henselae. Antibiotics. 8(2). 50–50. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong Wei Breakdown of academic impact, for papers by Jongwoo Kim Breakdown of academic impact, for papers by Yunzhang Hu Breakdown of academic impact, for papers by Adeline Kerviel Breakdown of academic impact, for papers by Xu-Hui Gao Breakdown of academic impact, for papers by Christina L. Rootes Breakdown of academic impact, for papers by Jessica Katy Skelton Breakdown of academic impact, for papers by Wenbo Sun Breakdown of academic impact, for papers by Mariluz Araínga
Rankless by CCL
2026